Evidence Based Mental Health最新文献_第6页

Evidence-Based Assessment and Management of Somatoform Disorders 躯体形式疾病的循证评估与管理

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-10-01 DOI: 10.1891/9780826167279.0006

M. Dell, J. Campo, P. Lusk

引用次数: 0

Sexuality 性

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-10-01 DOI: 10.1891/9780826167279.0014

D. Morrison-Beedy

引用次数: 0

Diagnosing, Managing, and Preventing Mental Health Disorders in Children and Adolescents 诊断、管理和预防儿童和青少年的精神健康障碍

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-10-01 DOI: 10.1891/9780826167279.0002

引用次数: 0

Evidence-Based Assessment and Management of Depressive Disorders 抑郁症的循证评估和管理

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-10-01 DOI: 10.1891/9780826167279.0004

引用次数: 0

Evidence-Based Assessment and Management of Autism and Pervasive Developmental Disorder 自闭症与广泛性发育障碍的循证评估与管理

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-10-01 DOI: 10.1891/9780826167279.0009

V. Knapp, Deborah A. Napolitano, Holly E. Brown

引用次数: 0

Evidence-Based Assessment and Management of Trauma, Stressor-Related Disorders, Other Adverse Childhood Events, Bullying, and Violence 创伤、压力相关障碍、其他不良儿童事件、欺凌和暴力的循证评估和管理

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-10-01 DOI: 10.1891/9780826167279.0013

Jessica Kozlowski, P. Lusk

引用次数: 0

Evidence-Based Assessment and Management of Overweight and Obesity 超重和肥胖的循证评估和管理

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-10-01 DOI: 10.1891/9780826167279.0015

D. Jacobson, L. Small, B. Melnyk

引用次数: 0

IF. IF.

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-07-20 DOI: 10.1136/ebmental-2021-300301

Andrea Cipriani, Samuele Cortese, Toshi A Furukawa

引用次数: 0

COVID-19 vaccines, hesitancy and mental health. COVID-19疫苗、犹豫和心理健康。

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-05-01 DOI: 10.1136/ebmental-2021-300266

Katharine Smith, Sinéad Lambe, Daniel Freeman, Andrea Cipriani

{"title":"COVID-19 vaccines, hesitancy and mental health.","authors":"Katharine Smith, Sinéad Lambe, Daniel Freeman, Andrea Cipriani","doi":"10.1136/ebmental-2021-300266","DOIUrl":"https://doi.org/10.1136/ebmental-2021-300266","url":null,"abstract":"Factors involved include confidence (trusting or not the vaccine or provider), complacency (seeing the need or value of a vaccine) and convenience (easy, convenient access to the vaccine) 3 4 Importantly, attitudes to vaccination can change and people who are initially hesitant can still come to see a vaccine’s safety, efficacy and necessity 5 Developing strategies to address hesitancy is key 6 The expedited development and relative novelty of the COVID-19 vaccines have led to public uncertainty 4 In addition, efforts to explain the mode of action of these vaccines involve a degree of complexity (eg, immune response and genetic mechanisms), which is difficult to communicate quickly and simply Suggestions for change include offering specific discussions from mental health professionals and peer workers, vaccine education and awareness focused for those with SMI, vaccination programmes within mental health services (with coexistent organisational change to facilitate this), alignment with other preventative health strategies (such as influenza vaccination, smoking cessation, metabolic monitoring), focused outreach and monitoring uptake 13 Monitoring of vulnerable groups vaccine uptake itself presents problems In the case of mental illness, multiple long-term conditions across mental and physical health domains as well as socio-economic factors means that both vulnerability and inequality are likely to be additive 11 However, vaccine impact may be greater among the most vulnerable despite lower vaccine uptake because the baseline absolute risk is so high 15 Therefore, in the context of a COVID-19 vaccine programme, even if vaccine uptake falls short in some high-risk groups, even small increases in vaccine uptake will still have significant health benefits 14 Uptake of vaccination is crucial both for the individual and protection of others","PeriodicalId":12233,"journal":{"name":"Evidence Based Mental Health","volume":"24 2","pages":"47-48"},"PeriodicalIF":5.2,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmental-2021-300266","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10212221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 28

Vital exhaustion in women with chest pain and no obstructive coronary artery disease: the iPOWER study. 胸痛且无阻塞性冠状动脉疾病的女性生命衰竭:iPOWER研究

IF 5.2 2区医学

Evidence Based Mental Health Pub Date : 2021-05-01 DOI: 10.1136/ebmental-2020-300175

Daria Frestad Bechsgaard, Ida Gustafsson, Marie Mide Michelsen, Naja Dam Mygind, Adam Pena, Hannah Elena Suhrs, Kira Bove, Jens Dahlgaard Hove, Eva Prescott

{"title":"Vital exhaustion in women with chest pain and no obstructive coronary artery disease: the iPOWER study.","authors":"Daria Frestad Bechsgaard, Ida Gustafsson, Marie Mide Michelsen, Naja Dam Mygind, Adam Pena, Hannah Elena Suhrs, Kira Bove, Jens Dahlgaard Hove, Eva Prescott","doi":"10.1136/ebmental-2020-300175","DOIUrl":"https://doi.org/10.1136/ebmental-2020-300175","url":null,"abstract":"Background: More than half of women with symptoms suggestive of myocardial ischaemia have no obstructive coronary artery disease (CAD), yet they face a higher risk of cardiovascular mortality and morbidity. Both vital exhaustion (VE) and depression have been linked to adverse cardiovascular prognosis in patients with CAD. We aimed to assess whether symptomatic women with no obstructive CAD are more vitally exhausted compared with asymptomatic women. Furthermore, we investigated the overlap between the constructs of VE and depression.Methods: Prevalence and burden of VE was assessed in symptomatic women with no obstructive CAD (n=1.266) and asymptomatic women (n=2.390). Among symptomatic women, we also assessed chest pain characteristics and symptoms of Hospital Anxiety and Depression Questionnaire.Findings: Median (IQR) VE score was 4 (1-9) and 2 (0-5) in symptomatic and asymptomatic women, respectively (age adjusted, p<0.001). The risk of severe VE was significantly higher in symptomatic women compared with asymptomatic women (OR 3.3, 95% CI 2.5 to 4.4), independent of age and risk factors, and was associated with symptom severity. VE and depression scores were correlated but principal component cluster analysis (PCCA) showed clear distinctiveness between the two constructs.Conclusions: Women with chest pain and no obstructive CAD are more vitally exhausted compared with asymptomatic women. PCCA showed that VE is distinct from depression in symptomatic women.Clinical implications: Mental health screening focusing on depressive symptomatology in women with chest pain presenting with symptoms of mental and physical exhaustion may overlook VE in these patients.","PeriodicalId":12233,"journal":{"name":"Evidence Based Mental Health","volume":"24 2","pages":"49-55"},"PeriodicalIF":5.2,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231582/pdf/ebmental-2020-300175.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10581481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3